Table 3.

Factors associated with low area-level SES at cancer diagnosis in the cohort of children with ALL in the NCDB, diagnosed between 2004 and 2019

VariableOR (95% CI)P value
Race/ethnicity (ref: non-Hispanic White) 
Non-Hispanic Black 10.44 (8.27-13.19) <.001 
American Indian/Alaska Native 15.13 (6.20-36.90) <.001 
Hispanic 12.84 (10.87-15.17) <.001 
Primary payer at diagnosis (ref: private) 
Medicaid 8.98 (7.82-10.31) <.001 
Other/uninsured 4.94 (3.77-6.48) <.001 
Unknown 5.42 (3.71-7.92) <.001 
Charlson-Deyo score (ref: none), ≥1 1.48 (1.16-1.88) .002 
Time to treatment (ref: within 1 week), >1 week 1.40 (1.16-1.68) <.001 
Distance in miles (ref: ≤50) 
51-100 8.49 (6.65-10.83) <.001 
>100 5.14 (3.95-6.69) <.001 
Rural-urban continuum codes (ref: metro), non-metro/rural 18.02 (13.64-23.81) <.001 
VariableOR (95% CI)P value
Race/ethnicity (ref: non-Hispanic White) 
Non-Hispanic Black 10.44 (8.27-13.19) <.001 
American Indian/Alaska Native 15.13 (6.20-36.90) <.001 
Hispanic 12.84 (10.87-15.17) <.001 
Primary payer at diagnosis (ref: private) 
Medicaid 8.98 (7.82-10.31) <.001 
Other/uninsured 4.94 (3.77-6.48) <.001 
Unknown 5.42 (3.71-7.92) <.001 
Charlson-Deyo score (ref: none), ≥1 1.48 (1.16-1.88) .002 
Time to treatment (ref: within 1 week), >1 week 1.40 (1.16-1.68) <.001 
Distance in miles (ref: ≤50) 
51-100 8.49 (6.65-10.83) <.001 
>100 5.14 (3.95-6.69) <.001 
Rural-urban continuum codes (ref: metro), non-metro/rural 18.02 (13.64-23.81) <.001 

or Create an Account

Close Modal
Close Modal